Oryzon Genomics SA (ORY)

Oryzon Genomics SA has recorded no insider trading activity within the last 90 days. The most recent transaction occurred on September 21, 2022, when a director sold 36,900 shares. Given that this activity dates back more than three months, there is no recent pattern of insider buying or selling to report.
Ticker: ORY Exchange: MCE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oryzon Genomics SA. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Sale 21 Sep 2022
Value €4,654,662.36 | Price 315.38 | Shares 66,783
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2022-09-27 2022-09-21 S Sale

DIRECTOR DE DESARROLLO DE NEGOCIO

Officer
66,783
315.38
€4,654,662
66,783 315.38 €4,654,662
2021-02-27 2021-02-26 S Sale

Consejera dominical

Director
1,499
164.72
€3,608,293
1,499 164.72 €3,608,293
2020-12-30 2020-12-29 S Sale

Consejera

Director
66,631
14.70
€3,298,466
66,631 14.70 €3,298,466
2020-12-30 2020-12-29 S Sale

Consejero

Director
250,000
3.72
€930,000
250,000 3.72 €930,000